Condition

Stomach Cancer

ClinicalTrials.gov condition label

Clinical trials31
Recruiting9
Common interventions25
Lead sponsors shown15

Clinical trials

31 shown
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer ImmunotherapyNCT07039474 · 2026-09-08
RECRUITING
A Phase 1 Study of IM-1617 in Participants With Advanced CancerNCT07578571 · 2026-05-21
RECRUITING
A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid TumorsNCT07354711 · 2026-01-04
RECRUITING
Large Language Models Assist in Tumor MDTNCT07504367 · 2026-01-01
RECRUITING
Brodalumab in the Treatment of Immune-Related Adverse EventsNCT06673329 · 2025-03-11
RECRUITING
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal CancerNCT06532799 · 2024-09-10
RECRUITING
Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast CancerNCT06199895 · 2023-11-28
RECRUITING
Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and TreatmentNCT05426135 · 2022-06-01
RECRUITING
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseNCT05366881 · 2022-05-03
RECRUITING
Enhanced Assistance During Radiotherapy for Unmet Essential NeedsNCT06582849 · 2024-10-04
COMPLETED
Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - ItalyNCT06161233 · 2023-05-16
COMPLETED
GI Organ Tracking Via Balloon ApplicatorsNCT05471401 · 2023-04-25
WITHDRAWN
Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer PatientsNCT05638048 · 2022-07-10
COMPLETED
Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and TreatmentNCT06653478 · 2022-06-01
UNKNOWN
The Registry of Oncology Outcomes Associated With Testing and TreatmentNCT04028479 · 2021-05-05
COMPLETED
PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision MedicineNCT05697198 · 2021-04-19
COMPLETED
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)NCT04825834 · 2021-03-22
COMPLETED
Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid CancerNCT05931445 · 2021-01-26
ACTIVE_NOT_RECRUITING
Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients?NCT04797624 · 2021-01-15
COMPLETED
Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern TherapyNCT04215861 · 2019-10-01
UNKNOWN
A Safety and Tolerability Study of INCAGN02390 in Select Advanced MalignanciesNCT03652077 · 2018-09-24
COMPLETED
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsNCT03662204 · 2018-08-23
COMPLETED
Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric CancerNCT03030404 · 2017-01-27
COMPLETED
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.NCT03384511 · 2016-09-30
COMPLETED
Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual SurvivalNCT02055313 · 2012-05-01
COMPLETED
Cancer in Patients With Gabapentin (GPRD)NCT01236053 · 2010-06-01
COMPLETED
A Study With Health Educational Material on Health Promotion in Cancer SurvivorsNCT00948337 · 2009-08-01
UNKNOWN
Comparison of Standard of Care or Treatment on ProtocolNCT01010334 · 2009-03-01
TERMINATED
Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer TumorsNCT00511576 · 2007-08-01
TERMINATED
Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing CancersNCT00291473 · 2005-07-01
COMPLETED
A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among WomenNCT00342004 · 1997-05-01
COMPLETED

Common interventions

Blood Sample CollectionOTHER218F-G1DRUG13H-10000DRUG1ApatinibDRUG1Balloon-tipped catheterDEVICE1Biomarker Testing (L)DIAGNOSTIC_TEST1Brochure of Secondary Cancer ScreeningBEHAVIORAL1BrodalumabDRUG1CAPABLE cohortDEVICE1CHP-HER2, CHP-NY-ESO-1DRUG1CT scanRADIATION1CyclophosphamidDRUG1e-PRO monitoringOTHER1Enhanced assistanceOTHER1FludarabineDRUG1Gabapentin prescriptionsDRUG1Gastric cancer surgeryPROCEDURE1Health education on routine grip strength trainingBEHAVIORAL1IM-1617DRUG1INCAGN02390DRUG1Interleukin-2DRUG1LLM assists in MDT report writingOTHER1MGCD0103 & DocetaxelDRUG1No InterventionOTHER1OmniSeq TestDIAGNOSTIC_TEST1

Trial status mix

COMPLETED15
RECRUITING9
UNKNOWN3
TERMINATED2
ACTIVE_NOT_RECRUITING1
WITHDRAWN1

Phase mix

NA7
PHASE17
PHASE24
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.